Detalhe da pesquisa
1.
Clinical Outcomes With Abemaciclib After Prior CDK4/6 Inhibitor Progression in Breast Cancer: A Multicenter Experience.
J Natl Compr Canc Netw
; : 1-8, 2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761455
2.
A Gene Panel Associated With Abemaciclib Utility in ESR1-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression.
JCO Precis Oncol
; 7: e2200532, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37141550